Institutional members access full text with Ovid®

Share this article on:

PHARMACOLOGIC VITREOLYSIS: Rationale, Potential Indications, and Promising Agents

Gandorfer, Arnd MD

doi: 10.1097/IAE.0b013e31825bc4df

Klinikum der Universität München, Munich, Germany.

Reprint requests: Arnd Gandorfer, MD, Augenklinik der Universität München, Mathildenstraße 8, 80336 München, Germany; e-mail:

The author declares no conflict of interest.

A. Gandorfer is a consultant for ThromboGenics.

© The Ophthalmic Communications Society, Inc.